Supplement trends,
and what holds up.

The useful part of this trend is unglamorous: enough protein, resistance training, creatine, and soluble fiber for the constipation that follows slowed gastric emptying. Products sold as natural GLP-1 boosters have far thinner human data than the drugs whose name they borrow, and none of them replicate the effect size.

The strength and lean-mass data is about as strong as supplement evidence gets. The cognitive and mood work is genuinely interesting but earlier stage, and the clearest signals show up under sleep deprivation and stress rather than in rested, well-fed adults. Monohydrate is the form with the trial record. HCl and gummies are convenience formats, not upgrades, and gummies have had real content-verification problems.

Most adults do benefit from more protein than the RDA, and the case is strongest after fifty, where anabolic resistance means a larger per-meal dose is needed to trigger the same muscle response. What rarely matters is the specific product. Whey and pea both work when total daily intake and leucine content are matched, so the useful comparison is grams per dollar, not the marketing on the front.

Magnesium and glycine have modest but real effects on sleep quality. Melatonin is a timing signal rather than a sedative, which is why it earns its keep for jet lag and shift work and disappoints as a nightly sleeping pill, and most retail products are dosed five to ten times higher than the trials that worked. Apigenin is the most talked-about ingredient here with the least human data behind it.

Ashwagandha has the best trial record in this group for perceived stress, and the branded standardized extracts are where those trials were actually run, so the extract matters more than the herb name. Saffron and rhodiola are reasonable second picks. What almost nothing supports is the premise underneath the trend, that a typical stressed adult has a measurable cortisol disorder a capsule corrects. Adrenal fatigue is not a recognized diagnosis.

Urolithin A has the cleanest human mechanism data of the group, with trials showing effects on mitophagy markers and muscle endurance. Nicotinamide riboside reliably raises blood NAD+, though whether that translates into something you would notice remains open. NMN has the weakest human record of the three and an unresolved regulatory status in the US. Senolytics like fisetin look promising in animals and remain thin in people.

Strain specificity is the right direction, because effects genuinely do not generalize across a genus and a species name on a label tells you very little. Akkermansia is the most interesting new organism with one of the smallest human datasets. Colostrum's real evidence sits in exercise-induced gut permeability and upper respiratory infections, and dose deserves care here, since the very high intakes are not uniformly favorable.

Non-hormonal options are modest but real for specific symptoms: standardized hop extract and black cohosh have the better vasomotor data, saffron has mood data in women over fifty. Red clover's isoflavone results are mixed. The interventions with the largest long-term payoff are the least marketable ones, protein and resistance training, because bone and lean mass loss outlast the hot flashes.

This is one of the rare trends where the population-level advice and the trial data point the same way, since most adults eat roughly half the fiber they should. Psyllium has the deepest record for cholesterol and regularity. Partially hydrolyzed guar gum is the gentlest option for sensitive guts. Inulin works but is the most likely to produce gas, so ramp slowly and take fiber with real water.

The category's biggest problem is not efficacy, it is what is actually in the tub. Mycelium grown on grain is largely grain, so look for fruiting body and a stated beta-glucan percentage rather than a total polysaccharide figure, which counts the starch. Lion's mane has the most human cognitive data of the group and it is still small and short. Turkey tail's best evidence is clinical adjunct work, not everyday wellness.

If you sweat heavily, train long, work in heat or eat low carb, sodium replacement is real and useful. For a sedentary adult drinking a thousand milligram sodium packet at a desk, the case is much weaker, and anyone managing blood pressure should look at that number twice. The specs worth comparing are sodium per serving, the potassium to sodium ratio, added sugar, and cost per serving. Flavor variety is not a spec.

Methylene blue is a prescription drug with genuine pharmacology and genuine risks, including serotonin syndrome when combined with SSRIs and SNRIs, and hemolysis in people with G6PD deficiency. It is not a dietary supplement, purity of consumer-grade material is inconsistent, and the human cognitive work is small and mostly acute imaging studies rather than outcomes anyone would feel. Treat this cluster as pharmacology, and involve a clinician.